Aclarubicin in Single Agent and Combined Chemotherapy of Adult Acute Myeloid Leukemia

  • P. S. Mitrou
Conference paper

Abstract

The present contribution summarizes the results of treating acute myeloid leukemia (AML) with aclarubicin (ACM) in three consecutive studies. Some of the results have recently been published elsewhere [1–3].

Keywords

Toxicity Leukemia Diarrhea Doxorubicin Bilirubin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mitrou PS, Kuse R, Anger H et al. (1985) Aclarubicin ( Aclacinomycin A) in the treatment of relapsing acute leukaemias. Eur J Cancer Clin Oncol 21: 919–923PubMedCrossRefGoogle Scholar
  2. 2.
    Mitrou PS (1985) Aclarubicin in single agent and combined chemotherapy of acute myeloid leukaemias. Eur J Haematol 38 (Suppl 47): 59–65CrossRefGoogle Scholar
  3. 3.
    Oka S, Mathe G, Mitrou PS (1984) Cancer Treat Rev 11: 299–302PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • P. S. Mitrou
    • 1
  1. 1.Süddeutsche HämoblastosegruppeFrankfurt/MainGermany

Personalised recommendations